Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Gabby Mahoney
Eczema Management Practical Tips
Prof Deborah Bateson AM
Oral Contraception Updates
Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes
Prof Rodney Baber AM
Menopausal Hormone Therapy and its Cardiovascular Benefits
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
